SURMOUNT-5: Tirzepatide and semaglutide go head-to-head in battle of weight loss drugs
top of page
Browse by category
Search
Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the company’s tirzepatide (Mounjaro)...
Study finds lower sleeve volume after banded-LSG could be key to less weight recurrence vs. LSG
Sleeve volume could play a crucial role in lower rates of weight recurrence after banded laparoscopic sleeve gastrectomy (BLSG), compared...
‘Obesity: The Big Truth’ – dispelling misconceptions and myths about obesity
In January 2020, Dr Andrew Jenkinson published his best-selling book - ‘Why We Eat (Too much)?’ – in which he outlined the emerging new...
Surgery more effective than medications and lifestyle interventions for metabolic liver disease
Bariatric and metabolic surgery is more effective than medications and lifestyle interventions for the treatment of advanced...
DiRECT study: 23% of participants remained in T2DM remission at five years
The latest results from a three-year extension of the DiRECT study reveal that for some people it’s possible to stay in remission from...
Sleeve gastrectomy in adolescents decreased strength and volumetric BMD of the lumbar spine
Sleeve gastrectomy (SG) decreases strength and bone mineral density of the lumbar spine in adolescents, according to the outcomes from a...
Ali Aminian receives Top Ten Clinical Research Achievement Award
A Cleveland Clinic landmark study on obesity and cancer, led by Dr Ali Aminian, director of Cleveland Clinic’s Bariatric & Metabolic...
Browse by tag
bottom of page